Intranasal epinephrine produced pharmacodynamic results that were comparable with or higher than autoinjectors and manual injection, according to a study published in Annals of Allergy, Asthma & ...
Aug. 9 (UPI) --The U.S. Food and Drug Administration on Friday announced the approval of the first nasal spray for treatment of anaphylaxis, a life-threatening allergic reaction. The epinephrine nasal ...
LOUISVILLE, Ky. — A sublingual film delivered sufficient concentrations of epinephrine to the blood faster than autoinjectors, according to a study presented at the American College of Asthma & ...
ARS Pharmaceuticals' Neffy nasal spray showed 89.2% success in treating anaphylaxis in 545 patients, comparable to epinephrine injections. FDA approved Neffy in 2024 for adults and children over 30 kg ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback